To the Editor:
We thank Prof. Toussirot for providing data on new-onset psoriasis in patients taking rituximab (RTX) for rheumatoid arthritis (RA)1. His case report is well documented, with a dermatologist confirmation and a typical illustration of psoriasis, although no biopsy was performed. In this case, a link between RTX therapy and new-onset psoriasis is suggested. Nevertheless, it …
Address correspondence to Prof. Claudepierre; E-mail: pascal.claudepierre{at}hmn.aphp.fr